Vimarsana
Biggest News Aggregation in the World

Page 3 - Jason Baggaley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jason Baggaley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jason Baggaley Today - Breaking & Trending Today

New rules curb impact investing for smaller Australian funds | Asset Owners - Vimarsana News

New rules curb impact investing for smaller Australian funds | Asset Owners

New regulations mean a single large allocation to an impact fund could risk creating underperformance across the fund as a whole making them too risky for smaller funds, say analysts.

abrdn Property Income Trust Limited - Disposal, Asset Management and Valuation Update - Vimarsana News

abrdn Property Income Trust Limited - Disposal, Asset Management and Valuation Update

abrdn Property Income Trust Limited - Disposal, Asset Management and Valuation Update PR Newswire London, October 5 abrdn Property Income Trust Limited (an authorised

abrdn Property Income Trust Limited - Sale of Asset - Vimarsana News

abrdn Property Income Trust Limited - Sale of Asset

abrdn Property Income Trust Limited - Sale of Asset PR Newswire London, August 3 abrdn Property Income Trust Limited (an authorised closed-ended investment company

Approval signals green light for COVID-19 test availability in UK - Vimarsana News

Approval signals green light for COVID-19 test availability in UK

Following approval in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) Regulations 2021 (“CTDA”) for its RIDA®GENE Flu & SARS-CoV-2 multiplex test (PG6825), international clinical diagnostics company R-Biopharm (Darmstadt) which has a significant Glasgow-based operation is now working to resume the sale of the product in the UK. Click to read more...

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation - Vimarsana News

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

R-Biopharm announces that the company’s RIDA®GENE Flu & SARS-CoV-2 multiplex test (PG6825) has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) Regulations 2021 (“CTDA”).